Since its inception, the Hemoglobin, Albumin, Lymphocyte, Platelet Score (HALP) has
gained attention as a new prognostic biomarker to predict several clinical outcomes in a …

This review assesses how publications interpret factors that influence the serum or plasma
albumin (PA) level in prognostic indices, focusing on inflammation and nutrition. On …

Purpose HALP score consisting of hemoglobin content, albumin content, lymphocyte count,
and platelet count can comprehensively evaluate the inflammatory response and nutritional …

Purpose Our study aimed to comprehensively analyze the association between anemia and
systemic inflammation in older patients with cancer. Methods This multicenter prospective …

Background Systemic inflammation and glucose metabolism have been closely related to
the survival of cancer patients. Therefore, we aimed to evaluate whether preoperative …

In cancer, activation of platelets by tumor cells is critical to disease progression.
Development of precise antiplatelet targeting may improve outcomes from anticancer …

Purpose To explore the correlation between hemoglobin, albumin, lymphocyte count,
platelet count (HALP) score and type 2 diabetic retinopathy (DR). Methods The study was …

Introduction As a composite immunonutritional biomarker, the Hemoglobin, Albumin,
Lymphocyte, Platelet (HALP) score has shown promise in assessing a patient's overall …

Aim The hemoglobin, albumin, lymphocyte, and platelet (HALP) score reflects the immune
system and the nutritional status of patients, and prognosis in various cancers. However, the …

Background and Objectives: Dyslipidemia is a major risk factor for cardiovascular disease
(CVD). The identification of new biomarkers that may enhance the risk assessment of lipid …